Employment Agreement between VectivBio AG and Luca Santarelli 2 / 12Employment Agreement • May 31st, 2023 • VectivBio Holding AG • Biological products, (no disgnostic substances)
Contract Type FiledMay 31st, 2023 Company Industry
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 31st, 2023 • VectivBio Holding AG • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 31st, 2023 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 11, 2023, by and between VectivBio US, Inc. (the “Company”), and Kevin Harris (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
April 29, 2023 Luca Santarelli, M.D. Chief Executive Officer VectivBio Holding AG Aeschenvorstadt 36Exclusivity Agreement • May 31st, 2023 • VectivBio Holding AG • Biological products, (no disgnostic substances)
Contract Type FiledMay 31st, 2023 Company Industry
Confidentiality Agreement VECTIVBIO HOLDING AG NON-DISCLOSURE AGREEMENTConfidentiality Agreement • May 31st, 2023 • VectivBio Holding AG • Biological products, (no disgnostic substances)
Contract Type FiledMay 31st, 2023 Company IndustryThis Non-Disclosure Agreement (this “Agreement”) is entered into between VectivBio Holding AG, a stock corporation (Aktiengesellschaft) incorporated and existing under the laws of Switzerland, having its registered office at Aeschenvorstadt 36, 4051 Basel, Switzerland, and registered with the commercial register of the Canton of Basel-Stadt under the company identification number CHE-289.024.902 (the “Company”) and Ironwood Pharmaceuticals, Inc. (the “Recipient”) as of March 29, 2023 (the “Effective Date”), to protect the confidentiality of certain confidential information of the Company to be disclosed to the Recipient solely for use in evaluating, pursuing and, if applicable, consummating a business relationship with the Company (the “Permitted Use”).
Employment Agreement dated as of May 11, 2023 by and between VectivBio AG (hereinafter the Company) Aeschenvorstadt 36, 4051 Basel, Switzerland and Claudia D’Augusta (hereinafter the Manager) (Company and Manager hereinafter individually or...Employment Agreement • May 31st, 2023 • VectivBio Holding AG • Biological products, (no disgnostic substances)
Contract Type FiledMay 31st, 2023 Company IndustryThe Manager is hereby employed by the Company and is directly subordinated and shall report to the Chief Executive Officer (CEO) of the Company and of the VectivBio Group (the Group). The Manager will be expected to assume the position of Chief Financial Officer and perform all duties commonly associated with such position. The Manager’s duties and responsibilities shall be those periodically assigned to the Manager and those set forth below as well as those set forth in the organizational regulations of the board of directors of VectivBio Holding, a corporation with its registered office in Basel (VectivBio Holding), (the Board) and the board of directors of the Company as periodically amended and the directives, policies and regulations periodically issued by the Company or VectivBio Holding.
Employment Agreement dated as of May 11, 2023 by and between VectivBio AG Aeschenvorstadt 36, 4051 Basel, Switzerland (hereinafter the Company) and Omar Khwaja (hereinafter the Manager) (Company and Manager hereinafter individually or collectively...Employment Agreement • May 31st, 2023 • VectivBio Holding AG • Biological products, (no disgnostic substances)
Contract Type FiledMay 31st, 2023 Company Industry